Benzinga's M&A Chatter for Tuesday November 10, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday November 10, 2015: Molson Coors Close to Deal to Acquire Remaining MillerCoors Stake from SABmiller The Rumor:
Molson Coors Brewing Co TAP is said to be close to a deal to acquire the remainder of the MillerCoors LLC U.S. joint venture, as reported by The Wall Street Journal on Tuesday. SABMiller's SBMRY 58% stake in the venture would cost Molson Coors roguhly $12 billion, according to sources. That deal would clear the way for the acquisition of SABMiller by Anheuser-Busch InBev BUD. Moslon Coors shares rose 1 Tuesday, closing at $88.31. Morgan Stanley Note Mentions Intercept as Potential Takeover Target for Amgen The Analyst Note:
Intercept ICPT shares surged higher Tuesday, on a note from Morgan Stanley which mentioned it a possible takeover target for Amgen AMGN. A spokesperson for Intercept told Benzinga there was no other news to account for the move. Intercept shares rose as high as $217.99 on Tuesday, closing at $205.97, up 7%. Astellas to Acquire Ocata Therapeutics for $8.50/Share in Cash The Deal:
Astellas Pharma Inc. ALPMY and Ocata Therapeutics, Inc. OCAT announced Tuesday, that have agreed that Astellas will acquire Ocata through Astellas subsidiary Laurel Acquisition Inc., for $8.50 per share in cash. The acquisition will be made by way of tender offer. Ocata Therapeutics shares rose 89% Tuesday, closing at $8.44.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsRumorsM&AMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!